Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Alexandrov, Ludmil B

University Of California, San Diego
United States

Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition 5U01CA290479-03 Wendy Wang, Ph.D., M.Sc.
Allen, Peter J

Duke University
United States

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas 5R01CA182076-08 Matthew Young, Ph.D.
Amuta, Ann Oyare

University Of Texas Arlington
United States

Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women 1R15CA294297-01 Goli Samimi, Ph.D., M.P.H.
Anderson, Garnet L.

Fred Hutchinson Cancer Center
United States

NCI Cancer Screening Research Network: Coordinating and Communication Center 3UG1CA286954-02S1 Elyse LeeVan, M.D., M.P.H.
Anderson, Daniel M

Healthpartners Institute
United States

Metro-Minnesota Community Oncology Research Consortium (MMCORC) 3UG1CA189863-12S1 Vanessa A. White, M.P.H.
Anderson, Daniel M

Healthpartners Institute
United States

Metro-Minnesota Community Oncology Research Consortium (MMCORC) 3UG1CA189863-12S1 Vanessa A. White, M.P.H.
Anderson, Karen Sue

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-03 Wendy Wang, Ph.D., M.Sc.
Anderson, Karen Sue

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-03 Wendy Wang, Ph.D., M.Sc.
Arnold, Corey Wells

University Of California Los Angeles
United States

Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification 5R01CA279666-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-03
Backman, Vadim

Northwestern University At Chicago
United States

Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification 1R01CA289294-01A1 Claire Zhu, Ph.D.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.
Bae-Jump, Victoria Lin

Univ Of North Carolina Chapel Hill
United States

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer 5R37CA226969-07 Goli Samimi, Ph.D., M.P.H.
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 3UG1CA189971-11S1 Vanessa A. White, M.P.H.
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 3UG1CA189971-11S1 Vanessa A. White, M.P.H.

Clinical Trials

Status
Title Sort descending Intervention Sponsor Status
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources Internet-Based Intervention - CONNECT, Patient Navigation, Support for Caregiver - Generic List, Support for Caregiver - Personalized List Wake Forest University Health Sciences Enrolling by invitation
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy Best Practice, Educational Intervention, Motivational Interviewing, Quality-of-Life Assessment, Questionnaire Administration, Text Message-based Navigation Intervention Alliance for Clinical Trials in Oncology Active, not recruiting
An Internet-based Program to Help Cancer Survivors Manage Pain Internet-based pain coping skills program Wake Forest University Health Sciences Recruiting
An Observational Research Study to Uncover Subtypes of Cancer Cachexia Biospecimen Collection, Computed Tomography, Electronic Medical Record, Medical Device Usage and Evaluation, Physical Performance Testing, Positron Emission Tomography, Survey Administration University of Rochester NCORP Research Base Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics Non-interventional Study Wake Forest University Health Sciences Recruiting
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Behavioral Intervention, Compliance Monitoring, Laboratory Biomarker Analysis, Mercaptopurine, Questionnaire Administration, Standard Follow-Up Care Children's Oncology Group Active, not recruiting
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy University of Rochester NCORP Research Base Enrolling by invitation
Axillary Reverse Mapping in Preventing Lymphedema in Patients with Breast Cancer Undergoing Axillary Lymph Node Dissection Axillary Lymph Node Dissection, Isosulfan Blue, Mapping, Quality-of-Life Assessment, Questionnaire Administration Alliance for Clinical Trials in Oncology Active, not recruiting
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors Biospecimen Collection, Bupropion Hydrochloride Controlled-release, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration University of Rochester NCORP Research Base Recruiting
Cancer and Blood Pressure Management, CARISMA Study Best Practice, Blood Pressure Measurement, Clinical Management, Quality-of-Life Assessment, Questionnaire Administration ECOG-ACRIN Cancer Research Group Active, not recruiting